Global Viscosupplementation Market to Reach US$ 8.7 Billion by 2032, Stimulated by Increasing Prevalence of Osteoporosis and Osteoarthritis

June 23, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2024-2032,” the global viscosupplementation market size reached US$ 4.5 Billion in 2023. Viscosupplementation is a medical procedure commonly used to provide relief to individuals suffering from osteoarthritis. It involves the injection of a gel-like substance directly into the affected joint. The injected fluid acts as a lubricant, reducing friction between the bones and allowing for smooth movement. The aim of viscosupplementation is to supplement the diminished levels of hyaluronic acid in the affected joint, thereby improving joint mobility, reducing pain, and potentially delaying the need for more invasive treatments, such as joint replacement surgery. Additionally, it restores the rheological properties of the synovial fluids, resulting in mechanical, analgesic, anti-inflammatory, and chondroprotective benefits. As a result, it is widely used for the treatment of osteoarthritis in the hip, knee, and hand.

Global Viscosupplementation Market Trends:

The global market is majorly driven by the increasing prevalence of osteoarthritis among the masses. Along with this, with the growing elderly population, there is a greater need for treatments that can alleviate joint pain and improve mobility, thus propelling the demand for viscosupplementation. Moreover, the increased awareness about treatment options and patient education regarding the benefits of viscosupplementation is significantly supporting the market. Besides, changing lifestyles, including sedentary habits and participation in sports activities, are also strengthening the market as these injuries lead to the development of osteoarthritis, further impelling the demand for viscosupplementation as a treatment option. Apart from this, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscles, spine, and nerves, is impacting the market favorably. Furthermore, several major companies are heavily investing in developing new formulations with enhanced properties, longer-lasting effects, and improved patient outcomes, thus providing a boost to the market. Additionally, ongoing technological advancements in delivery systems, such as pre-filled syringes and autoinjectors, are acting as another growth-inducing factor. Looking forward, the market value is projected to reach US$ 8.7 Billion by 2032, expanding at a CAGR of 7.42% during 2024-2032.  

Market Summary:

  • Based on the type, the market has been segmented into single, three and five injection. Currently, single injection represents the largest market segment.
  • On the basis of the age group, the market has been divided into adults and geriatric. Presently, geriatrics accounts for the largest market share.
  • Based on the distribution channel, the market has been bifurcated into hospital, retail, and online pharmacies. Among these, hospital pharmacies exhibit a clear dominance in the market.
  • On the basis of the application, the market has been categorized into knee osteoarthritis, hip osteoarthritis and hand osteoarthritis, and others. Presently, knee osteoarthritis accounts for the largest market share.
  • Based on the end use, the market has been segmented into hospitals, orthopedic clinics, and others. Among these, orthopedic clinics exhibit a clear dominance in the market.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Among these, North America holds the leading position in the market.
  • The competitive landscape of the market has also been examined, with some of the key players being Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, and Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited).

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Types Covered Single Injection, Three Injection, Five Injection
Age Groups Covered Adults, Geriatrics
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Applications Covered Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Others
End Uses Covered Hospitals, Orthopedic Clinics, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Viscosupplementation Market to Reach US$ 8.7 Billion by 2032, Stimulated by Increasing Prevalence of Osteoporosis and Osteoarthritis
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More